Skip to content

Infra-Low Frequency Neurofeedback training in the treatment of patients with eating disorder and comorbid post-traumatic stress disorder

Infra-Low Frequency Neurofeedback training in the treatment of patients with eating disorder and comorbid post-traumatic stress disorder

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027826
Enrollment
36
Registered
2022-01-19
Start date
2019-05-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F50 F43.1

Interventions

Group 1: ILF-Neurofeedback (EEG-Neurofeedback), 12 30-minute-sessions over 6 weeks. Electrode placements: T4-P4, T3-T4, T4-Fp2. Individual adjustment of training frequency. In case of subjective bene
12 30-minute-sessions over 6 weeks. The participant watches a relaxing DVD showing nature scenes by choice while sitting in a comfortable armchair.

Sponsors

Parkland-Klinik Klinik für Psychosomatik und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of an eating disorder (ICD-10: F50.00-F50.9) and diagnosis of PTSD or incomplete PTSD (ICD-10: F43.1; F43.8)

Exclusion criteria

Exclusion criteria: Previous treatment experience with neurofeedback training; susceptibility to epileptic seizures

Design outcomes

Primary

MeasureTime frame
At the beginning and at the end of their treatment, all participants completed the Eating Disorder Examination-Questionnaire (EDE-Q) as a measure of eating disorder psychopathology with a global score and the four subscales Restraint, Eating Concern, Weight Concern, and Shape Concern. They also completed the Impact of Event Scale-Revised (IES-R) with a global score and three subscales (avoidance, hyperarousal, and intrusion) in order to assess symptoms of post-traumatic stress.

Secondary

MeasureTime frame
Increases in Body Mass Index over time (T0-T1) were calculated for participants who were underweight before treatment. Patients underwent regular supervised weight controls. Subjective benefit of the intervention received was estimated by all participants on a 0-10 scale at T1. Cases of treatment discontinuation were assessed in both groups.

Countries

Germany

Contacts

Public ContactAnna Winkeler

Parkland-KlinikKlinik für Psychosomatik und Psychotherapie

anna.winkeler@parkland-klinik.de05621-706676

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 12, 2026